Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Laryngeal Diseases 1 Head and Neck Neoplasms 1

Interventions

pembrolizumab 90 Blood Specimen Collection 41 Cyclophosphamide 37 Bevacizumab 36 Nivolumab 34 Standard of Care 32 Carboplatin 32 Surveys and Questionnaires 29 Paclitaxel 27 atezolizumab 25 Exercise 25 Pemetrexed 24 Cisplatin 24 Gemcitabine 23 Fluorouracil 22 Radiotherapy 20 Leucovorin 20 Dexamethasone 20 Oxaliplatin 18 Docetaxel 18 Rituximab 16 Irinotecan 16 Cetuximab 16 Drug Therapy 15 Doxorubicin 15 dostarlimab 14 Biopsy 14 130-nm albumin-bound paclitaxel 14 fludarabine 13 Prednisone 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × monalizumab × 1 year × Clear all

NCT06152523 2026-04-06

MONAMI

Assistance Publique - Hôpitaux de Paris

Phase 2 Withdrawn

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡